Association of estrogen receptor α gene PvuII and XbaI polymorphisms with non-small cell lung cancer
- PMID: 22740932
- PMCID: PMC3362470
- DOI: 10.3892/ol.2011.482
Association of estrogen receptor α gene PvuII and XbaI polymorphisms with non-small cell lung cancer
Abstract
Single nucleotide polymorphisms (SNPs) of the estrogen receptor (ER)-α have been found to be associated with various diseases at significantly different frequencies. However, whether any relationship exists between ER-α polymorphisms and lung cancer remains to be determined. In this study, 84 non-smoking, female, non-small cell lung cancer patients with various stages of disease and 234 cancer-free reference controls were enrolled to examine the association of ER-α polymorphisms in lung cancer. Two restriction SNP sites, PvuII and XbaI, in the first intron of the ER-α gene were genotyped by polymerase chain reaction-restriction fragment length polymorphism. The frequencies of the PvuII-XbaI haplotypes and genotypes in a Taiwanese population were revealed for the first time. Although the genotypic frequencies of two polymorphic sites of ER- α were in linkage disequilibrium for the lung cancer group (χ(2)=50.013, d.f.=4) and reference controls (χ(2)=60.797, d.f.=4); and 7 and 8 combined genotypes were present, respectively, the distribution and the major genotypes are different in the two groups (p<0.0001). The p-values for PvuII and XbaI genotypes were significantly different between the lung cancer and reference controls. The PP genotype presence was found to be significantly lower in the lung cancer group (P=0.005), whereas presence of the xx genotype was significantly higher (P=0.042). These findings suggested that the PP genotype had a lower risk of lung cancer; whereas the xx genotype had a higher risk. In comparison with other studies conducted in various populations, it is of note that the pX haplotype frequency of this study was higher than that of other studies, whereas the px haplotype was lower. Moreover, the Xx genotypic frequency of XbaI polymorphisms in the ER-α gene of the reference control group was found to be extremely high, whereas the xx genotypic frequency was extremely low. In conclusion, PvuII-XbaI polymorphisms of the ER-α gene were found to be associated with the risk, but not cancer severity, of non-small cell lung cancer in a Taiwanese population.
Figures
Similar articles
-
[The XbaI and PvuII gene polymorphisms of the estrogen receptor alpha gene in Chinese women with breast cancer].Zhonghua Wai Ke Za Zhi. 2005 Mar 1;43(5):290-3. Zhonghua Wai Ke Za Zhi. 2005. PMID: 15842934 Chinese.
-
Genetic polymorphims of estrogen receptor alpha -397 PvuII (T>C) and -351 XbaI (A>G) in a portuguese population: prevalence and relation with breast cancer susceptibility.Mol Biol Rep. 2013 Aug;40(8):5093-103. doi: 10.1007/s11033-013-2611-6. Epub 2013 May 12. Mol Biol Rep. 2013. PMID: 23666105
-
The relation of the XbaI and PvuII polymorphisms of the estrogen receptor gene and the CAG repeat polymorphism of the androgen receptor gene to peak bone mass and bone turnover rate among young healthy men.Osteoporos Int. 2005 Dec;16(12):1633-40. doi: 10.1007/s00198-005-1889-1. Epub 2005 Apr 13. Osteoporos Int. 2005. PMID: 15827868
-
Reduction in breast cancer susceptibility due to XbaI gene polymorphism of alpha estrogen receptor gene in Jordanians.Breast Cancer (Dove Med Press). 2017 Jan 24;9:45-49. doi: 10.2147/BCTT.S125652. eCollection 2017. Breast Cancer (Dove Med Press). 2017. PMID: 28182136 Free PMC article.
-
Association between Estrogen Receptor-α Gene XbaI and PvuII Polymorphisms and Periodontitis Susceptibility: A Meta-Analysis.Dis Markers. 2015;2015:741972. doi: 10.1155/2015/741972. Epub 2015 Nov 24. Dis Markers. 2015. PMID: 26688601 Free PMC article. Review.
Cited by
-
ESR1 PvuII (rs2234693 T>C) polymorphism and cancer susceptibility: Evidence from 80 studies.J Cancer. 2018 Jul 30;9(16):2963-2972. doi: 10.7150/jca.25638. eCollection 2018. J Cancer. 2018. PMID: 30123365 Free PMC article. Review.
-
Genetic susceptibility to lung cancer--light at the end of the tunnel?Carcinogenesis. 2013 Mar;34(3):487-502. doi: 10.1093/carcin/bgt016. Epub 2013 Jan 24. Carcinogenesis. 2013. PMID: 23349013 Free PMC article. Review.
-
Estrogen receptor alpha promotes smoking-carcinogen-induced lung carcinogenesis via cytochrome P450 1B1.J Mol Med (Berl). 2015 Nov;93(11):1221-33. doi: 10.1007/s00109-015-1300-4. Epub 2015 Jun 5. J Mol Med (Berl). 2015. PMID: 26041383
References
-
- Nagai MA, Brentani MM. Gene expression profiles in breast cancer to identify estrogen receptor target genes. Mini Rev Med Chem. 2008;8:448–454. - PubMed
-
- Ko YJ, Balk SP. Targeting steroid hormone receptor pathways in the treatment of hormone dependent cancers. Curr Pharm Biotechnol. 2004;5:459–470. - PubMed
-
- Zimmermann J, von Angerer E. Estrogenic and antiestrogenic activities of 2,4-diphenylfuran-based ligands of estrogen receptors alpha and beta. J Steroid Biochem Mol Biol. 2007;104:259–268. - PubMed
-
- Dunn CA, Clark W, Black EJ, Gillespie DA. Estrogen receptor activation function 2 (AF-2) is essential for hormone-dependent transactivation and cell transformation induced by a v-Jun DNA binding domain-estrogen receptor chimera. Biochim Biophys Acta. 2003;1628:147–155. - PubMed
-
- Couse JF, Lindzey J, Grandien K, Gustafsson JA, Korach KS. Tissue distribution and quantitative analysis of estrogen receptor-α (ER-α) and estrogen receptor-α (ER-α) messenger ribonucleic acid in the wild-type and ER-α knockout mouse. Endocrinology. 1997;11:353–365. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous